Sara Centonze

437 total citations
11 papers, 286 citations indexed

About

Sara Centonze is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Sara Centonze has authored 11 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Sara Centonze's work include Ovarian cancer diagnosis and treatment (3 papers), PARP inhibition in cancer therapy (3 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Sara Centonze is often cited by papers focused on Ovarian cancer diagnosis and treatment (3 papers), PARP inhibition in cancer therapy (3 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). Sara Centonze collaborates with scholars based in Italy, Germany and United States. Sara Centonze's co-authors include Anna Diana, Ferdinando De Vita, E. Franzese, Michele Orditura, Francesca Carlino, Fortunato Ciardiello, Sandro Pignata, Luigi Pio Guerrera, Marilena Di Napoli and Roberto Alfano and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Cells.

In The Last Decade

Sara Centonze

10 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Centonze Italy	6	154	152	58	40	38	11	286
Ivaylo Stoimenov Sweden	8	138 0.9×	311 2.0×	16 0.3×	38 0.9×	81 2.1×	16	424
Martyna Pakuła Poland	10	91 0.6×	143 0.9×	46 0.8×	45 1.1×	57 1.5×	15	289
Laetitia Marzi United States	7	132 0.9×	288 1.9×	75 1.3×	27 0.7×	49 1.3×	8	419
Zannel Blanchard United States	8	110 0.7×	183 1.2×	54 0.9×	46 1.1×	100 2.6×	11	383
Thippeswamy Gulappa United States	10	72 0.5×	211 1.4×	35 0.6×	57 1.4×	49 1.3×	14	324
Lanya Li China	7	132 0.9×	285 1.9×	9 0.2×	38 0.9×	79 2.1×	12	433
Michela Romano Italy	9	120 0.8×	180 1.2×	49 0.8×	25 0.6×	104 2.7×	11	370
Linara Gabitova United States	8	131 0.9×	172 1.1×	9 0.2×	61 1.5×	165 4.3×	18	387
Marina Riggio Argentina	8	97 0.6×	206 1.4×	22 0.4×	17 0.4×	63 1.7×	8	309
Xavier Bernard United States	4	90 0.6×	238 1.6×	7 0.1×	26 0.7×	42 1.1×	4	328

Countries citing papers authored by Sara Centonze

Since Specialization

Citations

This map shows the geographic impact of Sara Centonze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Centonze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Centonze more than expected).

Fields of papers citing papers by Sara Centonze

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Centonze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Centonze. The network helps show where Sara Centonze may publish in the future.

Co-authorship network of co-authors of Sara Centonze

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Centonze. A scholar is included among the top collaborators of Sara Centonze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Centonze. Sara Centonze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Centonze, Sara, et al.. (2024). Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine. Frontiers in Psychiatry. 15. 14 indexed citations

Racca, Luisa, Silvia Polidoro, Sara Centonze, et al.. (2023). Role of Diacylglycerol Kinases in Acute Myeloid Leukemia. Biomedicines. 11(7). 1877–1877. 4 indexed citations

Centonze, Sara, Luisa Racca, Elisa Ruffo, et al.. (2023). Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction. Frontiers in Immunology. 14. 1043603–1043603. 3 indexed citations

Centonze, Giorgia, et al.. (2022). ROCK ‘n TOR: An Outlook on Keratinocyte Stem Cell Expansion in Regenerative Medicine via Protein Kinase Inhibition. Cells. 11(7). 1130–1130. 5 indexed citations

Centonze, Sara, et al.. (2021). Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1. International Journal of Molecular Sciences. 22(11). 5816–5816. 5 indexed citations

Centonze, Sara, Daniela Capello, Ricardo M. Biondi, et al.. (2021). Identification of Key Phospholipids That Bind and Activate Atypical PKCs. Biomedicines. 9(1). 45–45. 9 indexed citations

Centonze, Sara, E. Franzese, Anna Diana, et al.. (2020). Gestational choriocarcinoma with residual lung tumor after completing treatment: a case report. INFM-OAR (INFN Catania). 5(6). e107–e107.

Franzese, E., Anna Diana, Sara Centonze, et al.. (2020). PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?. Frontiers in Oncology. 10. 11 indexed citations

Franzese, E., Sara Centonze, Anna Diana, et al.. (2019). Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response. Frontiers in Oncology. 9. 1289–1289. 11 indexed citations

10.

Diana, Anna, E. Franzese, Sara Centonze, et al.. (2018). Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs. Current Oncology Reports. 20(10). 76–76. 69 indexed citations

11.

Franzese, E., Sara Centonze, Anna Diana, et al.. (2018). PARP inhibitors in ovarian cancer. Cancer Treatment Reviews. 73. 1–9. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact